Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
The report details the trend, potential and market size of Infantile Spasms Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Infantile Spasms Therapeuticsmarket, defines the market attractiveness level of Infantile Spasms Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Infantile Spasms Therapeutics industry, describes the types of Infantile Spasms Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Infantile Spasms Therapeutics market and the development prospects and opportunities of Infantile Spasms Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Infantile Spasms Therapeutics market in Chapter 13.
By Player:
Catalyst Pharmaceuticals
GW Pharmaceuticals
Valerion Therapeutics
Retrophin
Mallinckrodt
Orphelia Pharma
Insys Therapeutics
H Lundbeck
Anavex Life Sciences
By Type:
Oral
Injection
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Infantile Spasms Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Infantile Spasms Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Infantile Spasms Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Infantile Spasms Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Infantile Spasms Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.2 United States Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.3 Europe Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.4 China Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.5 Japan Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.6 India Infantile Spasms Therapeutics Consumption (2017-2022)
-
7.7 South Korea Infantile Spasms Therapeutics Consumption (2017-2022)
8 Region and Country-wise Infantile Spasms Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Infantile Spasms Therapeutics Consumption Forecast (2022-2028)
9 Global Infantile Spasms Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Infantile Spasms Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Infantile Spasms Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Infantile Spasms Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Infantile Spasms Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Infantile Spasms Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Infantile Spasms Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Infantile Spasms Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Infantile Spasms Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Infantile Spasms Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Infantile Spasms Therapeutics Market Competitive Analysis
-
14.1 Catalyst Pharmaceuticals
-
14.1.1 Catalyst Pharmaceuticals Company Details
-
14.1.2 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Service
-
14.2 GW Pharmaceuticals
-
14.2.1 GW Pharmaceuticals Company Details
-
14.2.2 GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GW Pharmaceuticals Infantile Spasms Therapeutics Product and Service
-
14.3 Valerion Therapeutics
-
14.3.1 Valerion Therapeutics Company Details
-
14.3.2 Valerion Therapeutics Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Valerion Therapeutics Infantile Spasms Therapeutics Product and Service
-
14.4 Retrophin
-
14.4.1 Retrophin Company Details
-
14.4.2 Retrophin Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Retrophin Infantile Spasms Therapeutics Product and Service
-
14.5 Mallinckrodt
-
14.5.1 Mallinckrodt Company Details
-
14.5.2 Mallinckrodt Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mallinckrodt Infantile Spasms Therapeutics Product and Service
-
14.6 Orphelia Pharma
-
14.6.1 Orphelia Pharma Company Details
-
14.6.2 Orphelia Pharma Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Orphelia Pharma Infantile Spasms Therapeutics Product and Service
-
14.7 Insys Therapeutics
-
14.7.1 Insys Therapeutics Company Details
-
14.7.2 Insys Therapeutics Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Insys Therapeutics Infantile Spasms Therapeutics Product and Service
-
14.8 H Lundbeck
-
14.8.1 H Lundbeck Company Details
-
14.8.2 H Lundbeck Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 H Lundbeck Infantile Spasms Therapeutics Product and Service
-
14.9 Anavex Life Sciences
-
14.9.1 Anavex Life Sciences Company Details
-
14.9.2 Anavex Life Sciences Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Anavex Life Sciences Infantile Spasms Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Infantile Spasms Therapeutics
-
Figure Infantile Spasms Therapeutics Picture
-
Table Global Infantile Spasms Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Infantile Spasms Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Infantile Spasms Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Infantile Spasms Therapeutics Consumption by Country (2017-2022)
-
Figure United States Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Infantile Spasms Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Infantile Spasms Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Infantile Spasms Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Infantile Spasms Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Infantile Spasms Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Catalyst Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Service
-
Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Infantile Spasms Therapeutics Product and Service
-
Table Valerion Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Valerion Therapeutics Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valerion Therapeutics Infantile Spasms Therapeutics Product and Service
-
Table Retrophin (Foundation Year, Company Profile and etc.)
-
Table Retrophin Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Retrophin Infantile Spasms Therapeutics Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Infantile Spasms Therapeutics Product and Service
-
Table Orphelia Pharma (Foundation Year, Company Profile and etc.)
-
Table Orphelia Pharma Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orphelia Pharma Infantile Spasms Therapeutics Product and Service
-
Table Insys Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Insys Therapeutics Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insys Therapeutics Infantile Spasms Therapeutics Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Infantile Spasms Therapeutics Product and Service
-
Table Anavex Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Anavex Life Sciences Infantile Spasms Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anavex Life Sciences Infantile Spasms Therapeutics Product and Service
-
